Characteristics of computed tomography perfusion parameters in non-small-cell-lung-cancer and its relationship to histology, size, stage an treatment response
- PMID: 29223410
- DOI: 10.1016/j.clinimag.2017.12.001
Characteristics of computed tomography perfusion parameters in non-small-cell-lung-cancer and its relationship to histology, size, stage an treatment response
Abstract
Objectives: To analyze computed tomography perfusion (CTP) parameters in NSCLC.
Materials and methods: Prospective study, 152 patients with NSCLC. CTP parameters were correlated with histology, stage, size and response to conventional chemotherapy/radiotherapy.
Results: Neuroendocrine tumours presented higher BV (p 0.002). Negative correlation of PMB (p 0.003) and positive of MTT (p 0.046) with T stage was found. BF showed negative correlation with size. No differences were found with the RECIST levels of response to chemotherapy/radiotherapy.
Conclusions: CTP parameters were highly variable. Neuroendocrine tumours presented higher BV and PMB values. Perfusion parameters do not differ depending on the stage and do not predict response to treatment.
Keywords: Computed tomography; Imaging biomarker; Lung; Lung cancer; Perfusion imaging.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Evaluation of response to conventional chemotherapy and radiotherapy by perfusion computed tomography in non-small cell lung cancer (NSCLC).Eur Radiol Exp. 2019 Jun 13;3(1):23. doi: 10.1186/s41747-019-0101-x. Eur Radiol Exp. 2019. PMID: 31197486 Free PMC article.
-
Assessment of bronchial and pulmonary blood supply in non-small cell lung cancer subtypes using computed tomography perfusion.Invest Radiol. 2015 Mar;50(3):179-86. doi: 10.1097/RLI.0000000000000124. Invest Radiol. 2015. PMID: 25500892
-
Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy.AJR Am J Roentgenol. 2009 Oct;193(4):1090-6. doi: 10.2214/AJR.08.1367. AJR Am J Roentgenol. 2009. PMID: 19770333
-
Evaluation of lung tumor response to therapy: Current and emerging techniques.Diagn Interv Imaging. 2016 Oct;97(10):1053-1065. doi: 10.1016/j.diii.2016.09.001. Epub 2016 Sep 29. Diagn Interv Imaging. 2016. PMID: 27693090 Review.
-
Diagnostic Performance of Perfusion Computed Tomography for Differentiating Lung Cancer from Benign Lesions: A Meta-Analysis.Med Sci Monit. 2019 May 11;25:3485-3494. doi: 10.12659/MSM.914206. Med Sci Monit. 2019. PMID: 31077263 Free PMC article.
Cited by
-
Expression of engrailed homeobox 2 regulates the proliferation, migration and invasion of non-small cell lung cancer cells.Oncol Lett. 2018 Jul;16(1):536-542. doi: 10.3892/ol.2018.8693. Epub 2018 May 10. Oncol Lett. 2018. PMID: 29963129 Free PMC article.
-
Evaluation of response to conventional chemotherapy and radiotherapy by perfusion computed tomography in non-small cell lung cancer (NSCLC).Eur Radiol Exp. 2019 Jun 13;3(1):23. doi: 10.1186/s41747-019-0101-x. Eur Radiol Exp. 2019. PMID: 31197486 Free PMC article.
-
ORP8 induces apoptosis by releasing cytochrome c from mitochondria in non‑small cell lung cancer.Oncol Rep. 2020 May;43(5):1516-1524. doi: 10.3892/or.2020.7517. Epub 2020 Feb 24. Oncol Rep. 2020. PMID: 32323800 Free PMC article.
-
An Orthogonally Clickable and Stimuli-Responsive Poly(β-amino ester) for the Co-delivery of Doxorubicin and BCL‑2 siRNA.ACS Appl Polym Mater. 2025 Jun 3;7(11):7013-7024. doi: 10.1021/acsapm.5c00608. eCollection 2025 Jun 13. ACS Appl Polym Mater. 2025. PMID: 40535829 Free PMC article.
-
Unlocking the predictive power of imaging biomarkers: predicting immune checkpoint therapy response in non-small cell lung cancer through baseline tumour vessel perfusions.BMJ Oncol. 2024 Aug 21;3(1):e000539. doi: 10.1136/bmjonc-2024-000539. eCollection 2024. BMJ Oncol. 2024. PMID: 39886149 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous